Tokyo, Sept. 20 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059127) titled 'Validity and reliability of the Japanese version of the Spine Oncology Study Group Outcomes Questionnaire 2.0 (SOSGOQ 2.0_JP) to evaluate health-related quality of life in patients with metastatic spinal tumors' on Sept. 20.
Study Type:
Observational
Primary Sponsor:
Institute - Fukushima Medical University
Condition:
Condition - Metastatic spinal tumors
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - To evaluate the reliability and validity of the Japanese version of the Spinal Oncology Study Group Outcomes Questionnaire (SOSGOQ 2.0_JP)
Basic objectives2 - Others
Eligibility:
Age-lower limit - 18
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - (1) Patients aged 18 years or older at the time of consent and whose native language is Japanese
(2) Patients whose primary tumor has been identified through imaging or other testing and who have been diagnosed with metastatic spinal tumors
(3) Patients with symptoms due to metastatic spinal tumors who are undergoing surgery or radiation therapy
(4) Patients who have consented to participate in this study
Key exclusion criteria - (1) Patients diagnosed with dementia
(2) Patients undergoing emergency surgery
(3) Patients with poor pain control at rest
(4) Patients with brain metastases
(5) Patients with impending or pathological fractures of the lower extremities
Target Size - 200
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2025 Year 07 Month 29 Day
Date of IRB - 2025 Year 09 Month 18 Day
Anticipated trial start date - 2025 Year 10 Month 01 Day
Last follow-up date - 2027 Year 12 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067639
Disclaimer: Curated by HT Syndication.
